LED chip, lamp and lighting fixture maker Cree Inc of Durham, NC, USA says that Anne Whitaker, president, North American Pharmaceuticals, of Sanofi S.A., has been appointed to its board of directors.
“Anne has proven herself to be a leader throughout her career and her extensive experience in strategic management and organizational development will be a tremendous asset,” says chairman & CEO Chuck Swoboda.
Whitaker joined Sanofi (a global and diversified healthcare firm) in September 2011. She currently oversees its operations in North America, and serves as a member of its Global Leadership Team and the US Regional Strategic Management Committee.
A graduate of the University of North Alabama with more than 20 years of experience, Whitaker began her career as a metabolic disease specialist with Upjohn Company. From there she joined GlaxoSmithKline as a sales representative. After holding leadership positions in GlaxoSmithKline’s commercial organization, in 2007 Whitaker became VP of Critical and Supportive Care before being appointed senior VP of Leadership and Organization Development from 2008 to 2009. In 2009, she became senior VP & business unit head, Cardiovascular, Metabolic and Urology (CVMU) at GlaxoSmithKline, where she had full commercial responsibility for leading, developing and managing strategic performance of the CVMU business.
